Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-17

Clinical Trial Update: Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) [NA]

View source ↗

Summary

A clinical trial (PreVail-PH2) is currently recruiting to evaluate the Gradient Denervation System for pulmonary artery denervation in heart failure patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gradient Denervation System

Snippet

Sponsor: Gradient Denervation Technologies | Conditions: Group 2 Pulmonary Hypertension, Heart Failure | NA | Status: RECRUITING